Oral Semaglutide Versus Empagliflozin, Sitagliptin and Liraglutide in the UK: Long-Term Cost-Effectiveness Analyses Based on the PIONEER Clinical Trial Programme
Date first appeared online 12/12/2019
DOI 10.1007/s13300-019-00736-6
Authors Bain S.
Journal Name Diabetes Therapy
Volume 11

Documents
  • 52765.pdf , Book, Released under the terms of a Creative Commons Attribution-NonCommercial 4.0 International License (CC-BY-NC).